Drug Development
Develops transdermal, oral, and topical pharmaceutical therapies.
Develops pharmaceutical therapies and drug delivery systems, with a focus on transdermal, oral, and topical treatments. Its programs address non-opioid pain management, central nervous system disorders, and dermatology. The company's portfolio includes Lidoderm and Versatis lidocaine patches, Docetaxel alcohol-free injection, and TPU-006, an investigational four-day dexmedetomidine patch for post-surgical pain. Teikoku Pharma USA conducts research and development in dosage form development, formulations, delivery mechanisms, and manufacturing. It also explores independent and collaborative drug development opportunities, including distribution and licensing arrangements. The company is located in San Jose, California.
Disclosure: Profile information has been compiled from publicly available sources and has not yet been verified by the business.
Category illustration. Illustrative image for this category. Not provided by the business.
Develops transdermal, oral, and topical pharmaceutical therapies.
Programs include non-opioid treatments and lidocaine patches.
Creates formulations and delivery mechanisms for therapies.
No reviews yet — be the first to review Teikoku Pharma USA Inc.
Sign in to write a review
No password needed. We only use your email to confirm the review is genuine.
No reviews match this filter.
Tell our moderators what is wrong with the review by this reviewer and we will take a look.